News Detail
![](pdf/covid-revised200323075624.jpg)
New Delhi, 19 March 2023: The Indian Council of Medical Research (ICMR) has issued revised guidelines for Covid-19 in the wake of the surge of cases in the past week across the country.
"View Details
"View Details
Source : ANI
Indian Council of Medical Research (ICMR)
ICMR
revised guidelines
Covid-19
Lopinavir-ritonavir
HCQ
Ivermectin
Convalescent plasma
Molnupiravir
Favipiravir
Azithromycin
Doxycycline
Related News
- Centre issues licences to 3,200 MedTech units; grants 10,000 import licences (26-07-2024)
- Maha FDA Seizes Rs 1.41 Crore Worth of Unlicensed Ayurvedic Drugs (26-07-2024)
- 424 drugs have been declared spurious/adulterated during 2022-23: Govt in LS (26-07-2024)
- ICMR releases 32 new treatment standards for treating common and serious diseases (26-07-2024)
- Indian national charged with selling counterfeit cancer drugs (26-07-2024)
- US FDA finds data integrity, sterility problems at Brassica Pharma (26-07-2024)
- DCA Raids Shops Selling Habit-Forming Drugs (25-07-2024)
- BIS Sanctioned 82 Medical Device projects to develop standards (25-07-2024)
- Anti-Narcotics Task Force will be formed soon in Rajasthan: HM (25-07-2024)
- ICMR to strengthen IPR unit to safeguard and commercialize scientific innovations (25-07-2024)